新的RSV疫苗在两个季节中将老年人的住院风险降低58%。 A new RSV vaccine reduces hospitalization risk by 58% for older adults over two seasons.

事实证明,单剂量的RSV疫苗可有效防止老年人连续两季住院,使与RSV有关的住院风险减少58%。 A single dose of the RSV vaccine has proven effective in preventing hospitalization for older adults over two consecutive seasons, reducing the risk of RSV-related hospitalization by 58%. 这项研究在日本医学协会发表,也表明心脏健康的潜在好处,尽管还需要开展更多的研究。 This study, published in JAMA, also suggests potential heart health benefits, although more research is needed. 疫苗会严重影响老年人的健康结果,他们特别容易受到RSV并发症的影响。 The vaccine could significantly impact health outcomes for the elderly, who are particularly vulnerable to RSV complications.